Skip to content

Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms

Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03479164
Enrollment
20
Registered
2018-03-27
Start date
2016-03-30
Completion date
2019-07-01
Last updated
2019-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic

Brief summary

The primary objective of this research project is development and validation of a new, non-contrast gated aortic (NCGA) computer tomography scan algorithm for screening of aortic aneurysm in the chest and abdomen in at risk patients. This study would initially be performed in patients with a known aneurysm and done in addition to their indicated surveillance CT scan.

Detailed description

Study Design: Patients who agree to enroll in the study will get the NCGA study as well as a routine non-contrast computed tomography of chest/abdomen/pelvis within one year following recruitment at the patient's convenience. No follow-up will be required, but any clinically relevant findings on the testing will be communicated to the PCP through EPIC in-basket. Urgent findings, as determined by the primary investigator, will also result in a direct communication with the PCP. It is expected that any such findings will also be seen on the standard and clinically indicated CT which they are also undergoing, and so new or unique findings on the study NCGA test are not expected to occur. The final study visit will be the day of participation. Study Design: Patients who agree to enroll in the study will get the NCGA study as well as a routine non-contrast computed tomography of chest/abdomen/pelvis within one year following recruitment at the patient's convenience. No follow-up will be required, but any clinically relevant findings on the testing will be communicated to the PCP through EPIC in-basket. Urgent findings, as determined by the primary investigator, will also result in a direct communication with the PCP. It is expected that any such findings will also be seen on the standard and clinically indicated CT which they are also undergoing, and so new or unique findings on the study NCGA test are not expected to occur. The final study visit will be the day of participation. Study Procedures: One visit to complete one (1) non-contrast (no dye/contrast material will be injected) computed tomography (CT) scan of the chest, abdomen and pelvis. This visit will occur within one year following recruitment, scheduled at the patient's convenience. This one visit represents the totality of study participation for each participant. Study Duration: For each individual, participation is only over one day - the day of the patient's non-contrast CT scan. No early termination visits or unscheduled visits apply. The anticipated duration to complete enrollment of all participants is 1 year. Following completion of the study, the study team is planning for an interim period of 6 months for discussion and planning for future projects.

Interventions

OTHERUltra Low-Dose CT

Ultra Low-Dose CT

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Adult patients who carry the diagnosis of thoracic aortic aneurysm, aortic dissection, or abdominal aortic aneurysm and require CT imaging to evaluate the pathology

Exclusion criteria

* Current pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of Ultra Low-Dose CTDay of ScanTo assess the sensitivity of NCGA for aortic aneurysm in the thoracic or abdominal aorta

Secondary

MeasureTime frameDescription
Radiation Exposure of Ultra Low-Dose CTDay of ScanTo assess the relative radiation exposure of NCGA to the patient in comparison to a standard CT

Other

MeasureTime frameDescription
Assess Findings of Ultra Low-Dose CTDay of ScanTo assess the success of limiting extraneous findings of the test.
Optimize Automation of Ultra Low-Dose CTDay of ScanTo optimize automation of the test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026